Quidel is a leading manufacturer of point-of-care diagnostic solutions with a successful track record in the USA. The company has recently expanded into the UK, introducing a new team of sales, support and marketing staff.
Quidel will also be sponsoring the exhibition’s POCT programme on Thursday 17 March.
Quidel has been an innovator in the medical devices industry for 40 years, including pioneering the first FDA-cleared POC test for influenza in 1999, and being the first to market a rapid SARS-CoV-2 antigen test in the USA. The company’s comprehensive product portfolio includes tests for a wide range of infectious diseases and cardiac biomarkers. Discover how Quidel’s rapid testing technologies can improve patient outcomes and provide economic benefits to healthcare systems.
Meet the team on Stand R12.
